Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Nathan

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Neurology. Clinical Practice|January 7, 2022
Subacute CNS Demyelination After Treatment With Immune Checkpoint InhibitorsElizabeth Tan, Heather Shaw, Paul Nathan, et al.
JMIR Human Factors|September 13, 2022
Developing a Provincial Surveillance and Support System for Childhood Cancer Survivors: Multiphase User-Centered Design StudyJennifer Shuldiner, Nida Shah, Catherine Reis, et al.
Neuro-Oncology Advances|June 7, 2022
Prognostic factors related to overall survival in adolescent and young adults with medulloblastoma: A systematic reviewHan Yan, Veda Zabih, Ute Bartels, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implicationsKarla A Lee, Heather M Shaw, Veronique Bataille, et al.
Radiology|August 5, 2011
Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarkerVicky Goh, Balaji Ganeshan, Paul Nathan, et al.
Current Medical Research and Opinion|March 16, 2010
Elicitation of health state utilities in metastatic renal cell carcinomaPaul Swinburn, Andrew Lloyd, Paul Nathan, et al.
Cancer Medicine|August 1, 2025
Patient-Reported Symptoms and Mental Health Event Risks in Adolescents and Young Adults With CancerSumit Gupta, Qing Li, Paul Nathan, et al.
BMC Cancer|June 6, 2017
Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated <sup>18</sup>F-Fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP studyChristian Kelly-Morland, Sarah Rudman, Paul Nathan, et al.
Reviews in Urology|November 12, 2016
Perioperative Considerations in Metastatic Renal Cell CarcinomaKate Flavin, Nikhil Vasdev, Jim Ashead, et al.
Anticancer Research|January 25, 2023
Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on PazopanibAnand Sharma, Amish Lakhani, Subhadip Ghosh-Ray, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Neurology. Clinical Practice|January 7, 2022
Subacute CNS Demyelination After Treatment With Immune Checkpoint InhibitorsElizabeth Tan, Heather Shaw, Paul Nathan, et al.
JMIR Human Factors|September 13, 2022
Developing a Provincial Surveillance and Support System for Childhood Cancer Survivors: Multiphase User-Centered Design StudyJennifer Shuldiner, Nida Shah, Catherine Reis, et al.
Neuro-Oncology Advances|June 7, 2022
Prognostic factors related to overall survival in adolescent and young adults with medulloblastoma: A systematic reviewHan Yan, Veda Zabih, Ute Bartels, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implicationsKarla A Lee, Heather M Shaw, Veronique Bataille, et al.
Radiology|August 5, 2011
Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarkerVicky Goh, Balaji Ganeshan, Paul Nathan, et al.
Current Medical Research and Opinion|March 16, 2010
Elicitation of health state utilities in metastatic renal cell carcinomaPaul Swinburn, Andrew Lloyd, Paul Nathan, et al.
Cancer Medicine|August 1, 2025
Patient-Reported Symptoms and Mental Health Event Risks in Adolescents and Young Adults With CancerSumit Gupta, Qing Li, Paul Nathan, et al.
BMC Cancer|June 6, 2017
Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated <sup>18</sup>F-Fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP studyChristian Kelly-Morland, Sarah Rudman, Paul Nathan, et al.
Reviews in Urology|November 12, 2016
Perioperative Considerations in Metastatic Renal Cell CarcinomaKate Flavin, Nikhil Vasdev, Jim Ashead, et al.
Anticancer Research|January 25, 2023
Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on PazopanibAnand Sharma, Amish Lakhani, Subhadip Ghosh-Ray, et al.
Pageof 13